Of the canonical pathways, the regulators of metabolism were most affected (Table 4; Supplementary Fig. 16) whilst MYC and STAT4 were predicted upstream regulators to be activated (Supplementary Table 9), as was the pathway modulating the anti-cancer pharmaceutical agent Streptozocin. This evidence concerns the gene MYC and cancer.